Chronic Kidney Disease (CKD)
Lupus Nephritis
- Obinutuzumab prescribing information
- The Lupus Initiative: Eliminating Health Disparities in Lupus
- KDIGO 2024 Clinical Practice Guideline for the Management of Lupus Nephritis
- 2024 American College of Rheumatology (ACR) Guideline for the Screening, Treatment, and Management of Lupus Nephritis
- Lupus Foundation of America: Lupus Nephritis Information Center
- National Kidney Foundation: Lupus Nephritis
- Lupus Health Disparities in the United States: A Framework of Barriers and Facilitators for Reducing Disease Burden in Racial and Ethnic Minorities
- New Treatment Regimens, New Drugs, and New Treatment Goals for Lupus Nephritis
- Novel Therapeutics for Management of Lupus Nephritis: What Is Next?
- Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
- Kidney Outcomes and Preservation of Kidney Function With Obinutuzumab in Patients With Lupus Nephritis: A Post Hoc Analysis of the NOBILITY Trial
- Anifrolumab in lupus nephritis: results from second-year extension of a randomised phase II trial



